Treatment outcome of creatine transporter deficiency: international retrospective cohort study

Theodora Bruun1, Sarah Sidky2, Anabela Bandeira3, F.G. Debray4, Can Fıçıcıoğlu5, Jennifer Goldstein6, Kairit Joost7, Dwight D. Koeberl6, Luísa Diogo8, Marie‐Cécile Nassogne9, Siobhán O’Sullivan10, Katrin Õunap7, Andreas Schulze11, Lionel Van Maldergem12, Gajja S. Salomons13, Saadet Mercimek‐Andrews14,15
1Genetics and Genome Biology Program, Research Institute, The Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G 1X8, Canada
2Division of Clinical and Metabolic Genetics, Department of Paediatrics, University of Toronto, The Hospital for Sick Children, Toronto, Canada
3Pediatrics, Metabolic Unit, Centro Materno Infantil do Norte, Centro Hospitalar do Porto, Porto, Portugal
4Service of Human Genetics, CHU Liège, University of Liège, Liège, Belgium
5Department of Pediatrics, Division of Human Genetics, The Children’s Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA
6Department of Pediatrics, Division of Medical Genetics, Duke University Medical Center, North, USA
7Department of Clinical Genetics, United Laboratories, Tartu University Hospital, Tartu, Estonia
8Metabolic Unit - Child Development Center, Hospital Pediátrico, Centro Hospitalar e Universitário de Coimbra (CHUC), Coimbra, Portugal
9Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Woluwe-Saint-Lambert, Belgium
10Department of Metabolic Paediatrics, Royal Hospital for Sick Children, Belfast, UK
11Departments of Paediatrics and Biochemistry, University of Toronto, Toronto, ON, Canada
12Center for Human Genetics, Franche-Comté University, Besançon, France
13Metabolic Unit, Department of Clinical Chemistry, VU University Medical Center, Amsterdam Neuroscience, Amsterdam, The Netherlands
14Genetics and Genome Biology Program, Research Institute, The Hospital for Sick Children, Toronto, Canada
15Institute of Medical Sciences, University of Toronto, The Hospital for Sick Children, Toronto, Canada

Tóm tắt

Từ khóa


Tài liệu tham khảo

Betsalel OT, Pop A, Rosenberg EH, Fernandez-Ojeda M, Creatine Transporter Research, Group, Jakobs C, Salomons GS (2012) Detection of variants in SLC6A8 and functional analysis of unclassified missense variants. Mol Genet Metab 105(4):596–601. https://doi.org/10.1016/j.ymgme.2011.12.022

Cecil KM, Salomons GS, Ball WS Jr et al (2001) Irreversible brain creatine deficiency with elevated serum and urine creatine: a creatine transporter defect? Ann Neurol 49(3):401–404. https://doi.org/10.1002/ana.79

Chilosi A, Leuzzi V, Battini R, Tosetti M, Ferretti G, Comparini A, Casarano M, Moretti E, Alessandrì MG, Bianchi MC, Cioni G (2008) Treatment with L-arginine improves neuropsychological disorders in a child with creatine transporter defect. Neurocase 14(2):151–161. https://doi.org/10.1080/13554790802060821

Fons C, Sempere A, Arias A, López-Sala A, Póo P, Pineda M, Mas A, Vilaseca MA, Salomons GS, Ribes A, Artuch R, Campistol J (2008) Arginine supplementation in four patients with X-linked creatine transporter defect. J Inherit Metab Dis 31(6):724–728. https://doi.org/10.1007/s10545-008-0902-1

Garcia P, Rodrigues F, Valongo C, Salomons GS, Diogo L (2012) Phenotypic variability in a Portuguese family with x-linked creatine transport deficiency. Pediatr Neurol 46(1):39–41. https://doi.org/10.1016/j.pediatrneurol.2011.10.005

Kleefstra T, Rosenberg EH, Salomons GS, Stroink H, van Bokhoven H, Hamel BCJ, de Vries BBA (2005) Progressive intestinal, neurological and psychiatric problems in two adult males with cerebral creatine deficiency caused by an SLC6A8 mutation. Clin Genet 68(4):379–381. https://doi.org/10.1111/j.1399-0004.2005.00489.x

Malheiro R, Diogo L, Garcia P, Fineza I, Oliviera G (2012) Cerebral creatine deficiency syndromes. Acta Medica Port 25(6):389–398

Mercimek-Mahmutoglu S, Salomons GS (2009) [updated 2015] Creatine deficiency syndromes. In: Pagon RA, Adam MP, Bird TD, Dolan CR, Fong CT, Stephens K (eds) GeneReviews® [internet]. Seattle: University of Washington, Seattle. http://www.ncbi.nlm.nih.gov/books/NBK3794/ . Accessed Nov 2016

Mercimek-Mahmutoglu S, Connolly MB, Poskitt KJ, Horvath GA, Lowry N, Salomons GS, Casey B, Sinclair G, Davis C, Jakobs C, Stockler-Ipsiroglu S (2010) Treatment of intractable epilepsy in a female with SLC6A8 deficiency. Mol Genet Metab 101(4):409–412. https://doi.org/10.1016/j.ymgme.2010.08.016

Salomons GS, van Dooren SJ, Verhoeven NM, Cecil KM, Ball WS, Degrauw TJ, Jakobs C (2001) X-linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome. Am J Hum Genet 68(6):1497–1500. https://doi.org/10.1086/320595

Sempere A, Fons C, Arias A et al (2009) Creatine transporter deficiency in two adult patients with static encephalopathy. J Inherit Metab Dis 32:S91–S96

Valayannopoulos V, Boddaert N, Chabli A, Barbier V, Desguerre I, Philippe A, Afenjar A, Mazzuca M, Cheillan D, Munnich A, de Keyzer Y, Jakobs C, Salomons GS, de Lonlay P (2012) Treatment by oral creatine, L-arginine and L-glycine in six severely affected patients with creatine transporter defect. J Inherit Metab Dis 35(1):151–157. https://doi.org/10.1007/s10545-011-9358-9

Van de Kamp JM, Pouwels PJ, Aarsen FK et al (2012) Long-term follow-up and treatment in nine boys with X-linked creatine transporter defect. J Inherit Metab Dis 35(1):141–149. https://doi.org/10.1007/s10545-011-9345-1

Van de Kamp JM, Betsalel OT, Mercimek-Mahmutoglu S et al (2013) Phenotype and genotype in 101 males with X-linked creatine transporter deficiency. J Med Genet 50(7):463–472. https://doi.org/10.1136/jmedgenet-2013-101658

Van de Kamp JM, Mancini GM, Salomons GS (2014) X-linked creatine transporter deficiency: clinical aspects and pathophysiology. J Inherit Metab Dis 37(5):715–733. https://doi.org/10.1007/s10545-014-9713-8